Purposeful
Athens
About Purposeful
Purposeful discovers new treatments and develops pharmaceutical products for rare diseases by repurposing previously marketed drugs. Their vision is to fully utilize AI repurposing and revisit rare and common diseases to reverse disease phenotypes. It collaborates with FRAXA and FRAXA-DVI to identify drug repurposing candidates for Fragile X Syndrome. They also identify drug repurposing candidates for Glioblastoma.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $200.0K
- Funding stage: Seed
- Last round: Pre-Seed (Oct 2018)
- Website: purposeful.eu
Industries & Categories
Artificial Intelligence (AI), Data Mining, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/purposeful-154188 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.